MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Henry Schein Inc

Suletud

SektorTervishoid

68.99 1.05

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

67.91

Max

69.46

Põhinäitajad

By Trading Economics

Sissetulek

-3M

96M

Müük

17M

3.2B

P/E

Sektori keskmine

22.456

63.778

Aktsiakasum

1.19

Kasumimarginaal

3.008

Töötajad

25,000

EBITDA

1M

237M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+16.69% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

6. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-1.8B

8.5B

Eelmine avamishind

67.94

Eelmine sulgemishind

68.99

Uudiste sentiment

By Acuity

44%

56%

150 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Henry Schein Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

29. jaan 2025, 13:28 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal

29. jaan 2025, 14:04 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

KKR Builds Stake in Medical-Supply Company -- 2nd Update

29. jaan 2025, 12:54 UTC

Omandamised, ülevõtmised, äriostud

KKR Builds Stake in Medical-Supply Company -- Update

29. jaan 2025, 12:07 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Sees 2025 Adjusted Ebitda Up Mid-Single Digits >HSIC

29. jaan 2025, 12:07 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Sees 2025 Revenue Up Low- to Mid-Single Digits >HSIC

29. jaan 2025, 12:06 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein: KKR Buying $250 Million in New Shares Based on Market Price >HSIC

29. jaan 2025, 12:06 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Sees 4Q Rev $3.2B >HSIC

29. jaan 2025, 12:03 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein: KKR Representatives Max Lin, William Daniel to Join Board >HSIC

29. jaan 2025, 12:03 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein: KKR Will Have Ability to Boost Stake to 14.9% via Open Market Purchases >HSIC

29. jaan 2025, 12:02 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Names Robert Hombach an Independent Director >HSIC

29. jaan 2025, 12:02 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Increases Share-Repurchase Program Authorization by $500 Million >HSIC

29. jaan 2025, 12:02 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Sees 2025 Adjusted EPS Up Low- to Mid-Single Digits >HSIC

29. jaan 2025, 12:01 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein Sees 4Q Adj EPS $1.19 >HSIC

29. jaan 2025, 12:00 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein, KKR to Collaborate Range of Value Creation Opportunities >HSIC

29. jaan 2025, 12:00 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Henry Schein: KKR to Become 12% Common Shareholder >HSIC

29. jaan 2025, 10:30 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

KKR Builds Stake in Medical-Supply Company, Reaches Deal for Board Seats -- WSJ

29. jaan 2025, 10:30 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein Has Already Been an Activist Target -- WSJ

29. jaan 2025, 10:30 UTC

Omandamised, ülevõtmised, äriostud

Private-Equity Firm KKR to Work to Improve Operations at Medical and Dental Supplier, Sources Say -- WSJ

29. jaan 2025, 10:30 UTC

Omandamised, ülevõtmised, äriostud

KKR Has Taken a Big Stake in Henry Schein, Will Get Two Board Seats, Sources Say -- WSJ

Võrdlus sarnastega

Hinnamuutus

Henry Schein Inc Prognoos

Hinnasiht

By TipRanks

16.69% tõus

12 kuu keskmine prognoos

Keskmine 79.92 USD  16.69%

Kõrge 90 USD

Madal 55 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Henry Schein Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

13 ratings

4

Osta

8

Hoia

1

Müü

Tehniline skoor

By Trading Central

68.765 / 70.7Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Weak Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

150 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.